Welcure Drugs & Pharmaceuticals Complete Financial Statements
WELCURE • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Welcure Drugs & Pharmaceuticals (WELCURE).
Downloads include all available records across all periods.
For market performance, see the
WELCURE stock price today
.
Profitability Ratios
Net Profit Margin
7.41%
2025 data
EBITDA Margin
11.11%
2025 data
Operating Margin
4.00%
2025 data
Return on Assets
0.75%
2025 data
Return on Equity
1.94%
2025 data
Balance Sheet Ratios
Current Ratio
1.48
2025 data
Debt to Equity
2.59
2025 data
Equity Ratio
38.58%
2025 data
Asset Turnover
0.10
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
+1344.4%
Year-over-Year
Net Profit Growth
+1600.0%
Year-over-Year
EBITDA Growth
+1400.0%
Year-over-Year
Expense Growth
+1337.5%
Year-over-Year
Assets Growth
+26600.0%
Year-over-Year
Equity Growth
+10200.0%
Year-over-Year
Liabilities Growth
+26600.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 390 | 27 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 345 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | 45 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit Margin % | 10.00% | 4.00% | 0.00% | 0.00% | 22.00% | 41.00% | -12.00% | 3.00% | -41.00% | 31.00% | 32.00% | 7.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 45 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 11 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 34 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Earnings Per Share (₹) | 3.20 | 0.36 | -0.13 | 0.08 | 0.02 | 0.05 | -0.01 | 0.00 | -0.02 | 0.02 | 0.07 | 0.00 |
Related Pages for Welcure Drugs & Pharmaceuticals
Additional stock information and data for WELCURE
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 267 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 182 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 267 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| LIABILITIES | |||||||||||
| Total Liabilities | 267 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 123 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 103 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Capital | 112 | 13 | 13 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 |
| Reserves & Surplus | -10 | -12 | -12 | -12 | -12 | -12 | -12 | -12 | -12 | -12 | -12 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -222 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | 222 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |